YEVGENIYA BAGDASAROVA: Open Payments
NPI 1699701102 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 28 payments from 12 companies in 2025. Trend: 2023 $523 · 2024 $1,143 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $263 |
| Sumitomo Pharma America, Inc. | 3 | $105 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Novo Nordisk Inc | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| ABIOMED | 1 | $30 |
| Alkermes, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $17 |
Products named: MOUNJARO, GEMTESA, HETLIOZ, CAPLYTA, Wegovy, FANAPT, Ozempic, VIVITROL.
Industry payments across CA — which companies pay providers there.
